Genitourinary Cancer
CAMPEP Credits: 0.50
MDCB Credits: 0.50
Please find the details of each abstract that will be highlighted in this session below:
Abstract #: 181Title: Long-term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide After Radical ProstatectomyPresenter: Karen E. Hoffman, MD, FASTRO
Abstract #: 317Title: Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: 2-Year Outcomes from the MIRAGE Randomized Clinical TrialPresenter: Amar U. Kishan, MD
Abstract #: 182Title: Quality of Life in Patients Enrolled in a Randomized Clinical Trial Evaluating Hypofractionated Radiotherapy for Intermediate Risk Prostate CancerPresenter: Noelia S. Sanmamed, MD, PhD
Abstract #: 183Title: Prospective Evaluation of Supplemental External Beam Radiotherapy in Higher-Risk Prostate Cancer Patients Implanted with Pd-103: Long-Term Results of the 44/20/0 TrialsPresenter: Martin T. King, MD, PhD
Abstract #: LBA 06Title: Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III TrialPresenter: Nicolas Demogeot, MD
Discussant: Rahul Tendulkar, MD, FASTRO – Cleveland Clinic Taussig Cancer Center